Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.
about
Diagnosis and Treatment of Disease Caused by Nontuberculous MycobacteriaPolyphasic characterization reveals that the human pathogen Mycobacterium peregrinum type II belongs to the bovine pathogen species Mycobacterium senegalense.Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteriaManagement of opportunist mycobacterial infections: Joint Tuberculosis Committee Guidelines 1999. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic SocietyImpact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990sClinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteriaAmoebal coculture of "Mycobacterium massiliense" sp. nov. from the sputum of a patient with hemoptoic pneumoniaMycobacteria and the new quinolonesSusceptibilities of nontuberculosis mycobacterial species to amoxicillin-clavulanic acid alone and in combination with antimycobacterial agentsSensitivity of fluorochrome microscopy for detection of Mycobacterium tuberculosis versus nontuberculous mycobacteriaRecurrent catheter-related infection caused by a single clone of Mycobacterium chelonae with two colonial morphotypes.Non-tuberculous mycobacterial tenosynovitis: a review.Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infectionsIntra- and interpatient variability of the hsp65 and 16S-23S intergenic gene region in Mycobacterium abscessus strains from patients with cystic fibrosisTetracycline resistance and presence of tetracycline resistance determinants tet(V) and tap in rapidly growing mycobacteria from agricultural soils and clinical isolates.Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.Multisite reproducibility of Etest for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitumClinical and laboratory features of Mycobacterium mageritense.Activities of linezolid against rapidly growing mycobacteria.Mycobacterium chelonae-abscessus complex associated with sinopulmonary disease, Northeastern USA.High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan.Activities of the glycylcyclines N,N-dimethylglycylamido-minocycline and N,N-dimethylglycylamido-6-demethyl-6-deoxytetracycline against Nocardia spp. and tetracycline-resistant isolates of rapidly growing mycobacteria.Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy.Epidemiology of infection by nontuberculous mycobacteriaAntimicrobial susceptibility patterns of Nocardia asteroides.Management of bacterial keratitis: beyond exorcism towards consideration of organism and host factors.Nontuberculous mycobacterial pulmonary infection in patients with cystic fibrosis: diagnosis and treatment.Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients.Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organismsAntimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.Permeability barrier to hydrophilic solutes in Mycobacterium cheloneiClinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases.Descriptive statistical analyses of serial dilution data.Comparative drug resistance of Mycobacterium abscessus and M. chelonae isolates from patients with and without cystic fibrosis in the United Kingdom.Evaluation of Etest for susceptibility testing of rapidly growing mycobacteriaThe Challenge of Pulmonary Nontuberculous Mycobacterial Infection.Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid.In vitro antimicrobial susceptibility of Mycobacterium abscessus in Korea.Disseminated folliculitis by Mycobacterium fortuitum in an immunocompetent womanAbscesses due to mycobacterium abscessus linked to injection of unapproved alternative medication.
P2860
Q22241907-ACD90198-CF8A-4445-A2E3-5389546B1266Q24535187-761E846B-991B-4CB3-8D28-4B60823DB1F4Q24535651-C158BC8A-C31E-4A63-B274-2EC9F51643EBQ24679338-AA03535B-ACA8-4385-94CD-EE0F5B2AE009Q24682974-D1035C68-F0D9-48BA-A26F-459A8BCAF078Q28278933-0B954024-EE5A-4F8A-9621-25CDE4D64BBDQ28297048-32FCB3E7-0618-4E39-BA33-5A923320F835Q28342507-163BE2D2-2A6A-4546-911F-B9FE023226A8Q28367441-10B2683F-805E-41D7-8733-7FEEA576667DQ33661885-66106DA0-C577-4078-AEEB-BD0DBBD8714BQ33667274-12767705-FFA4-4585-B460-EA745D66205BQ33730779-AD0D15EB-4DBC-4CA1-8AA0-E16E52C3B040Q33746042-604BB1BC-5D72-497B-ACB4-015BE5427F33Q33885049-49C58E6A-6EE9-4E2D-B600-BBC004A9C7B7Q33920300-835FBB02-BA8B-4E04-BBBF-A4FB3CEDBD58Q33960674-89ACF537-16CA-4348-A7BC-63AE8C9C3B6FQ33965384-B38807A4-4706-4CA0-9656-56DE35A1431BQ33965927-816DADE1-CB9A-42B0-9207-3E49B3FB3849Q33981613-673ACBE0-8B79-4010-94F6-B8498843E2EEQ34010278-4BF0073C-3E23-4B8D-9D44-210A0EAEB72FQ35014132-A0376F68-15DA-478D-B09F-5A028B1BBD99Q35123617-1CC9DF4E-D0A0-4376-8368-7CE372E70AFCQ35245733-9955FFA3-79B5-4C94-8627-B9BECF233CB5Q35370226-5D5FA334-FC97-4BFA-A328-4F96B2F31111Q35565721-C0E53664-FAE4-4064-AEBF-7D9527DFAC77Q35590415-836719CD-729D-43DC-8410-EEE9303ACA7BQ35627888-49F55975-EF68-42F6-80C7-065323B0CD3AQ35779935-F0E429D9-E75E-4F06-8C7F-173CB21031A8Q35843595-E28713B4-3826-4B34-B294-940F92CE9082Q36156072-ABA78525-B0FD-4F3E-ABC0-D49FA537262CQ36159221-3ACD28CB-62AE-47C9-B7E0-3BD64AF097DCQ36363027-F44CC40A-102F-4F75-883F-BFA0BB610A8EQ36451501-62D24D90-A17E-4B45-A7FE-2C7FA2F32BFCQ36506301-1959B99E-7796-4F93-B337-620B7A67DB05Q36523174-BEE3A00E-87C8-4E27-9BC8-D95B4B626B8BQ36567746-38254DEE-21EF-454C-9AF4-4F36503814DAQ36753494-94565398-E534-4761-8E92-3BC3AA3ED521Q36854356-A675D630-54C4-4B29-B483-E16D4B868997Q36977776-C2FC855E-A315-4256-A618-D40CC6A7A903Q37064426-C7F1AAB5-ABFA-4DFA-AFD2-57FDF4FD070C
P2860
Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Antimicrobial susceptibility o ...... um and Mycobacterium chelonae.
@ast
Antimicrobial susceptibility o ...... um and Mycobacterium chelonae.
@en
type
label
Antimicrobial susceptibility o ...... um and Mycobacterium chelonae.
@ast
Antimicrobial susceptibility o ...... um and Mycobacterium chelonae.
@en
prefLabel
Antimicrobial susceptibility o ...... um and Mycobacterium chelonae.
@ast
Antimicrobial susceptibility o ...... um and Mycobacterium chelonae.
@en
P2093
P2860
P356
P1476
Antimicrobial susceptibility o ...... um and Mycobacterium chelonae.
@en
P2093
Swenson JM
Thornsberry C
Wallace RJ Jr
P2860
P304
P356
10.1128/AAC.28.6.807
P407
P577
1985-12-01T00:00:00Z